Miney Paquette

Burlington, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

Journal: The oncologist
Published: November 24, 2025

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.

Journal: PloS one
Published: August 26, 2021

Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.

Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.

Journal: TH open : companion journal to thrombosis and haemostasis
Published: September 02, 2020

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.

Journal: Journal of clinical medicine
Published: May 15, 2020

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: March 17, 2020

Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.

Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.

Journal: ESC heart failure
Published: March 06, 2020

Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.

Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.

Journal: Journal of arrhythmia
Published: November 08, 2019

Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.

Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.

Journal: The American journal of cardiology
Published: August 15, 2019

A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation.

A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation.

Journal: Systematic reviews
Published: May 20, 2019

A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

Journal: Blood advances
Published: February 24, 2019

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: February 23, 2019

Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.

Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.

Journal: American heart journal
Published: January 19, 2019
Showing 1-12 of 19

Last Updated: 09/26/2026